Medtronic Reports Q1 Adj EPS $1.02 Vs Est $1.01, Sales $7.27B Vs Est $7.06B; Sees FY Adj EPS $4.30-$4.40 Vs Est $4.37 & Revs Up 6-8%

by Paul Quintaro, Benzinga Editor

September 3, 2015 7:19 AM | 2 seconds read | Make a Comment

FY 2016 EPS expecting $0.40-$0.50 FX Negative impact

Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.